Prevalence of Chronic Obstructive Pulmonary Disease and Its Associated Risk Factors in Yunnan Province, China: A Population Based Cross-Sectional Study

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2024 report. Available from: https://goldcopd.org/2024-gold-report/. Accessed May 14, 2024.
   Google Scholar
• Collins GS, Kolahi AA, Kaufman JS. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679. doi:10.1136/bmj-2021-069679
   PubMedGoogle Scholar
• World Health Organization. The top 10 causes of death.2020. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed May 14, 2024.
   Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Li M, Hanxiang C, Na Z, et al. Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open Respir Res. 2023;10(1):e001698. doi:10.1136/bmjresp-2023-001698
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nation- wide prevalence study. Lancet Respir Med. 2018;6:421–430. doi:10.1016/S2213-2600(18)30103-6
   PubMed Web of Science ®Google Scholar
• Yin P, Wu J, Wang L, et al. The burden of COPD in China and its provinces: findings from the global burden of disease study 2019. Front Public Health. 2022;10:859499. doi:10.3389/fpubh.2022.859499
   PubMedGoogle Scholar
• Chen J, Yin Y, Zhang Y, et al. Chronic obstructive pulmonary disease prevalence and associated risk factors in adults aged 40 years and older in southeast China: a cross-sectional study during 2019-2020. Int J Chron Obstruct Pulmon Dis. 2022;17:2317–2328. doi:10.2147/COPD.S377857
   PubMed Web of Science ®Google Scholar
• Zha Z, Leng R, Xu W, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in Anhui Province, China: a population-based survey. BMC Pulm Med. 2019;19(1):102. doi:10.1186/s12890-019-0864-0
   PubMedGoogle Scholar
• Wang R, Xu J, Wang Y. A population-based survey of the prevalence and risk factors of chronic obstructive pulmonary disease in Shanxi Province, China. Rev Clin Esp. 2022;222(4):218–228. doi:10.1016/j.rceng.2021.04.011
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85–95. doi:10.1080/15412550801940721
   PubMedGoogle Scholar
• Zhou YM, Chen SY, Tian J, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013;17(12):1645–1651. doi:10.5588/ijtld.12.0995
   PubMed Web of Science ®Google Scholar
• National Bureau of Statistics of China. 2020 Population Census; 2020. Available from: https://www.stats.gov.cn/english/Statisticaldata/yearbook/. Accessed May 14, 2024.
   Google Scholar
• Zheng YW, Huang B, Fan GH. Summary of the scope of the promotion effect of electronic health records combined with new media carriers on community residents’ health. Chine General Med. 2023;21(06):1048–1052. doi:10.6766/j.cnki.issn.10016.100100001106
   Google Scholar
• Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–872. doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e
   PubMed Web of Science ®Google Scholar
• Feng Y, Yu XH, Song YX, et al. Establishment of a predictive equation for pulmonary ventilation function in school-aged children in northeast China: a prospective study. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(11):1119–1126. doi:10.7499/j.issn.1008-8830.2108139
   PubMedGoogle Scholar
• Task Force for Pulmonary Function of Chinese Thoracic Society. Guidelines for Pulmonary Function Testing (Part 2) – spirometry. J Chine Tuberculosis Respir Dis. 2014;37(7):481–486. doi:10.3760/cma.j.issn.1001-0939.2014.07.001
   Google Scholar
• Task Force for Pulmonary Function of Chinese Thoracic Society. Guidelines for Pulmonary Function Testing (Part 4)—Bronchodilation Test. J Chine Tuberculosis Respir Dis. 2014;37(9):655–658. doi:10.3760/cma.j.issn.1001-0939.2014.09.007
   Google Scholar
• Jian W, Gao Y, Hao C, et al. Reference values for spirometry in Chinese aged 4-80 years. J Thorac Dis. 2017;9(11):4538–4549. doi:10.21037/jtd.2017.10.110
   PubMed Web of Science ®Google Scholar
• Siu AL, Bibbins-Domingo K; US Preventive Services Task Force (USPSTF), et al. Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:1372–1377. doi:10.1001/jama.2016.2638
   PubMed Web of Science ®Google Scholar
• Preventive Services Task Force US, Mangione CM, Barry MJ, et al. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2022;327(18):1806–1811. doi:10.1001/jama.2022.5692
   PubMed Web of Science ®Google Scholar
• Yawn BP, Duvall K, Peabody J, et al. The impact of screening tools on diagnosis of chronic obstructive pulmonary disease in primary care. Am J Prev Med. 2014;47(5):563–575. doi:10.1016/j.amepre.2014.07.030
   PubMed Web of Science ®Google Scholar
• Yawn BP, Martinez FJ. POINT: can Screening for COPD Improve Outcomes? Yes Chest. 2020;157(1):7–9. doi:10.1016/j.chest.2019.05.034
   PubMed Web of Science ®Google Scholar
• Siddharthan T, Pollard SL, Quaderi SA, et al. Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings. JAMA. 2022;327(2):151–160. doi:10.1001/jama.2021.23065
   PubMed Web of Science ®Google Scholar
• Li W, Huang K, Tang XY, et al. Analysis of screening status of high-risk population of chronic obstructive pulmonary disease in “Happy Breathing” project area. Chine J Health Management. 2022;16(02):77–82. doi:10.3760/cma.j.cn115624-20210503-00239
   Google Scholar
• Du M, Hu H, Zhang L, et al. China county based COPD screening and cost-effectiveness analysis. Ann Palliat Med. 2021;10(4):4652–4660. doi:10.21037/apm-21-812
   PubMed Web of Science ®Google Scholar
• Li YL. Prevalence and Influencing Factors Analysis of Chronic Obstructive Pulmonary Disease in Rural Areas of Gansu Province. Lanzhou University; 2021.
   Google Scholar
• Huang L. Prevalence and Influencing Factors Analysis of Chronic Obstructive Pulmonary Disease Among Residents Aged 40 Years and Above in Guizhou Province. Guizhou Medical University; 2022.
   Google Scholar
• Chen XY, Fang L, Zhao M, et al. Study on the prevalence and influencing factors of chronic obstructive pulmonary disease among residents aged 40 years and above in Zhejiang Province in 2019. Chine Jo Chronic Dis Prevention Control. 2023;31(02):96–100.
   Google Scholar
• Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi:10.1016/S2213-2600(21)00511-7
   PubMed Web of Science ®Google Scholar
• Global strategy for prevention, diagnosis and management of COPD: 2024 Report. Available from: https://goldcopd.org/2024-gold-report/. Accessed May 14, 2024.
   Google Scholar
• Chuchalin AG. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease (revised in 2021). Chine J Tuberculosis Respiration. 2021;44(3):36.
   Google Scholar
• Foreman MG, Wilson C, DeMeo DL, et al. Alpha-1 antitrypsin PiMZ genotype is associated with chronic obstructive pulmonary disease in two racial groups. Ann Am Thorac Soc. 2017;14(8):1280–1287. doi:10.1513/AnnalsATS.201611-838OC
   PubMed Web of Science ®Google Scholar
• Fell AKM, Svendsen MV, Kim JL, et al. Exposure to second-hand tobacco smoke and respiratory symptoms in non-smoking adults: cross-sectional data from the general population of Telemark, Norway. BMC Public Health. 2018;18(1):843. doi:10.1186/s12889-018-5771-4
   PubMedGoogle Scholar
• Yin L, Huang YL, Jin DH, et al. Analysis of the prevalence and influencing factors of chronic obstructive pulmonary disease among residents aged 40 years and above in Hunan Province. Chine Jo Chronic Dis Prevention Control. 2020;28(10):731–734.
   Google Scholar
• Soriano JB, Alfagemec I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021;57(1):61–69. doi:10.1016/j.arbres
   PubMed Web of Science ®Google Scholar
• Leung C, Bourbeau J, Sin DD, et al. The prevalence of chronic obstructive pulmonary disease (COPD) and the heterogeneity of risk factors in the Canadian population: results from the Canadian Obstructive Lung Disease (COLD) study. Int J Chron Obstruct Pulmon Dis. 2021;16:305–320. doi:10.2147/COPD.S285338
   PubMed Web of Science ®Google Scholar
• Hwang YI, Park YB, Yoo KH. Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis. 2017;80(3):226–229. doi:10.4046/trd.2017.80.3.226
   PubMed Web of Science ®Google Scholar
• Terzikhan N, Verhamme KMC, Hofman A, et al. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785–792. doi:10.1007/s10654-016-0132-z
   PubMed Web of Science ®Google Scholar
• Fragoso CA. Epidemiology of chronic obstructive pulmonary disease (COPD) in aging populations. COPD. 2016;13(2):125–129. doi:10.3109/15412555.2015.1077506
   PubMedGoogle Scholar
• Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991–996. doi:10.1016/S0140-6736(11)60990-2
   PubMed Web of Science ®Google Scholar
• Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–350. doi:10.1056/NEJMsa1211128
   PubMed Web of Science ®Google Scholar
• Cai L, Wang XM, Fan LM, et al. Socioeconomic variations in chronic obstructive pulmonary disease prevalence, diagnosis, and treatment in rural Southwest China. BMC Public Health. 2020;20(1):536. doi:10.1186/s12889-020-08687-5
   PubMed Web of Science ®Google Scholar
• Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370(9589):751–757. doi:10.1016/S0140-6736(07)61378-6
   PubMed Web of Science ®Google Scholar
• Hagstad S, Bjerg A, Ekerljung L, et al. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest. 2014;145(6):1298–1304. doi:10.1378/chest.13-1349
   PubMed Web of Science ®Google Scholar
• Terzikhan N, Verhamme KM, Hofman A, et al. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785–792. doi:10.1007/s10654-016-0132-z
   PubMed Web of Science ®Google Scholar
• Tang X, Lei J, Li W, et al. The relationship between BMI and lung function in populations with different characteristics: a cross-sectional study based on the enjoying breathing program in China. Int J Chron Obstruct Pulmon Dis. 2022;17:2677–2692. doi:10.2147/COPD.S378247
   PubMed Web of Science ®Google Scholar
• Ran PX, Wang C, Yao WZ, et al. Relationship between body mass index and chronic obstructive pulmonary disease and quality of life. Chine J Tuberculosis Respir Med. 2007;30(1):18–22.
   Google Scholar
• Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991;303(6804):671–675. doi:10.1136/bmj.303.6804.671
   PubMed Web of Science ®Google Scholar
• Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet. 2007;370(9589):758–764. doi:10.1016/S0140-6736(07)61379-8
   PubMed Web of Science ®Google Scholar
• Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881. doi:10.1016/S0140-6736(05)67632-5
   PubMed Web of Science ®Google Scholar
• Laniado-Laborin R, Rendón A, Bauerle O. Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population. Int J Tuberc Lung Dis. 2011;15(6):818–823. doi:10.5588/ijtld.10.0546
   PubMed Web of Science ®Google Scholar
• Xia JJ, Zou XX, Qiu Y, et al. Investigation and influencing factors analysis of chronic obstructive pulmonary disease among permanent residents aged 40 and above in Hongyuan County, Aba autonomous Prefecture, Sichuan Province. Shandong Med. 2022;63(05):51–54.
   Google Scholar
• Guo Y, Xing Z, Shan G, et al. Prevalence and Risk Factors for COPD at High Altitude: a Large Cross-Sectional Survey of Subjects Living Between 2100-4700 m Above Sea Level. Front Med Lausanne. 2020;7:581763. doi:10.3389/fmed.2020.581763
   PubMed Web of Science ®Google Scholar
• Horner A, Soriano JB, Puhan MA, et al. Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir Res. 2017;18(1):162. doi:10.1186/s12931-017-0643-5
   PubMedGoogle Scholar
• Lin A, Mao C, Rao B, et al. Development and validation of nomogram including high altitude as a risk factor for COPD: a cross-sectional study based on Gansu population. Front Public Health. 2023;11:1127566. doi:10.3389/fpubh.2023.1127566
   PubMed Web of Science ®Google Scholar
• Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J. 2019;53(2):1801193. doi:10.1183/13993003.01193-2018
   PubMed Web of Science ®Google Scholar